IP Library Granted Patent US 9,561,965
Granted Patent B2
US 9,561,965 · App. 14/649,092 · Granted Feb 7, 2017

Method for hydrogenating higher halogen-containing silane compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,561,965
App. No.
14/649,092
Granted
Feb 7, 2017
Kind
B2
Abstract

The present invention relates to a continuous process for hydrogenating halogen-containing silane compounds having at least three silicon atoms, in which at least one halogen-containing silane compound having at least three silicon atoms and at least one hydrogenating agent are converted continuously to form at least one hydridosilane compound having at least 3 silicon atoms and oxidized hydrogenating agent, and wherein oxidized hydrogenating agent is withdrawn and reduced, and the reaction product of this reduction reaction is sent back to the hydrogenation, to the hydridosilane compounds obtainable by this process and to the use thereof.

Claims (29)

1. A continuous process for hydrogenating halogen-containing silane compounds having at least three silicon atoms, comprising:

(i) continuously converting

at least one halogen-containing silane compound having at least three silicon atoms and at least one hydrogenating agent

to form

at least one hydridosilane compound having at least 3 silicon atoms and an oxidized hydrogenating agent;

(ii) withdrawing and reducing the oxidized hydrogenating agent, and

(iii) feeding back the reduced oxidized hydrogenating agent to (i).

2. The process according to claim 1 , wherein the halogen-containing silane compound has the generic formula Si n X 2n+2 where 3≦n≦10 and X═F, Cl, Br, and/or I.

3. The process according to claim 2 , characterized in that wherein the halogen-containing silane compound is Si 5 Cl 12 .

4. The process according to claim 1 , wherein the proportion of the at least one halogen-containing silane compound ranges from 10-30% by weight based on the total mass of the components fed in.

5. The process according to claim 1 , wherein the hydrogenating agent is selected from the group of compounds consisting of LiAlH 4 , NaBH 4 and i-Bu 2 AlH.

6. The process according to claim 1 , wherein the hydrogenating agent in the reduced state is metered in H equivalent proportions of 1.0 to 1.5 based on the sum total of halogen atoms to be hydrogenated.

7. The process according to claim 1 , wherein at least two series-connected reactors are used for the conversion.

8. The process according to claim 7 , wherein the molar ratio in the first reactor of reduced to oxidized hydrogenating agent ranges from 0.4 to 0.75.

9. The process according to claim 7 , wherein the first of the two or more series-connected reactors is a stirred tank reactor.

10. The process according to claim 7 , wherein at least one of the reactors connected downstream of the first reactor is a flow reactor.

11. The process according to claim 1 characterized in that it that follows on from a process for synthesizing halogenated silane compounds in which

i) at least one halosilane of the generic formula Si n X 2n+2 where n≧2 and X═F, Cl, Br and/or I and

ii) at least one catalyst selected from the group of the tertiary phosphines PR 3 , the tertiary amines NR 3 and the group of compounds of the generic formula NRR′ a R″ b Y c

where a=0 or 1, b=0 or 1, and c=0 or 1, and

where

aa) R, R′ and/or R″ is —C 1 -C 12 -alkyl, —C 1 -C 12 -aryl, —C 1 -C 12 -aralkyl, —C 1 -C 12 -aminoalkyl, —C 1 -C 12 -aminoaryl, —C 1 -C 12 -aminoaralkyl,

and/or

two or three R, R′ and R″ radicals, in the case that c=0, together form a cyclic or bicyclic, heteroaliphatic or heteroaromatic system including N,

with the proviso that at least one R, R′ or R″ radical is not —CH 3

and/or

bb) R and R′ and/or R″ (in the case that c=1) are —C 1 -C 12 -alkylene, —C 1 -C 12 -arylene, —C 1 -C 12 -aralkylene, —C 1 -C 12 -heteroalkylene, —C 1 -C 12 -heteroarylene, —C 1 -C 12 -heteroaralkylene and/or —N═, or

cc) (in the case that a=b=c=0) R═≡C—R′″ (where R′″═—C 1 -C 10 -alkyl, —C 1 -C 10 -aryl and/or —C 1 -C 10 -aralkyl),

are converted to form a mixture comprising at least one halosilane of the generic formula Si m X 2m+2 (where m>n and X═F, Cl, Br and/or I) and Si m−n X 2(m−n)+2 (where X═F, Cl, Br and/or I).

Assignments (2)
CHANGE OF NAME Recorded Jan 31, 2020
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051765/0166 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2015
From: OH, MIN-ZAE; HAUBROCK, JENS; SCHWAERTZKE, THORSTEN; MOUSSALLEM, IMAD; TROCHA, MARTIN
To: EVONIK DEGUSSA GMBH
Reel/Frame 035767/0518 →